Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-15 Sale | 2024-10-16 6:53 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $53.5 | $1,070,059 | 243,324 (Direct) | View |
| 2024-10-08 Sale | 2024-10-09 5:39 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 20,000 | $53.29 | $1,065,743 | 686,744 (Direct) | View |
| 2024-09-24 Sale | 2024-09-26 6:06 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $56.88 | $1,706,440 | 766,744 (Direct) | View |
| 2024-09-17 Sale | 2024-09-18 6:49 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $62.45 | $1,249,096 | 207,478 (Direct) | View |
| 2024-09-10 Sale | 2024-09-12 5:56 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $59.13 | $1,773,790 | 856,744 (Direct) | View |
| 2024-08-20 Sale | 2024-08-21 6:03 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $61.4 | $1,228,020 | 241,898 (Direct) | View |
| 2024-08-13 Sale | 2024-08-15 4:59 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $57.15 | $1,714,451 | 946,744 (Direct) | View |
| 2024-08-12 Sale | 2024-08-14 4:57 pm | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 29,881 | $56.53 | $1,689,294 | 69,874 (Direct) | View |
| 2024-07-23 Sale | 2024-07-24 5:48 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $55 | $1,100,023 | 221,752 (Direct) | View |
| 2024-07-22 Sale | 2024-07-23 4:37 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 5,000 | $53.93 | $269,662 | 15,480 (Direct) | View |
| 2024-06-26 Sale | 2024-06-28 4:06 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 30,000 | $51.93 | $1,557,940 | 60,480 (Direct) | View |
| 2024-06-18 Sale | 2024-06-20 4:17 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $49.43 | $494,260 | 179,891 (Direct) | View |
| 2024-06-11 Sale | 2024-06-13 4:15 pm | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 20,000 | $50.31 | $1,006,300 | 99,755 (Direct) | View |
| 2024-05-21 Sale | 2024-05-22 5:24 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $45.27 | $905,480 | 221,606 (Direct) | View |
| 2024-04-16 Sale | 2024-04-17 7:22 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $38.42 | $768,390 | 261,606 (Direct) | View |
| 2024-03-12 Sale | 2024-03-13 5:22 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $41.95 | $839,100 | 244,484 (Direct) | View |
| 2024-02-27 Sale | 2024-02-28 6:49 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $39.75 | $794,923 | 224,714 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-15 Exercise | 2024-10-16 6:53 pm | N/A 2029-02-12 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 243,324 (Direct) | View |
| 2024-10-15 Exercise | 2024-10-16 6:53 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 5,509 | $16.65 | 243,324 (Direct) | View |
| 2024-10-15 Exercise | 2024-10-16 6:53 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 14,491 | $19.98 | 243,324 (Direct) | View |
| 2024-10-08 Exercise | 2024-10-09 5:39 pm | N/A 2025-02-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 20,000 | $13.87 | 686,744 (Direct) | View |
| 2024-09-24 Exercise | 2024-09-26 6:06 pm | N/A 2025-02-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $13.87 | 766,744 (Direct) | View |
| 2024-09-17 Exercise | 2024-09-18 6:49 pm | N/A 2029-02-12 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 207,478 (Direct) | View |
| 2024-09-17 Exercise | 2024-09-18 6:49 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $16.65 | 207,478 (Direct) | View |
| 2024-09-10 Exercise | 2024-09-12 5:56 pm | N/A 2025-02-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $13.87 | 856,744 (Direct) | View |
| 2024-08-27 Exercise | 2024-08-27 7:49 pm | N/A 2028-02-14 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 5,580 | $0 | 173,756 (Direct) | View |
| 2024-08-27 Exercise | 2024-08-27 7:49 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 5,580 | $18.41 | 173,756 (Direct) | View |
| 2024-08-20 Exercise | 2024-08-21 6:03 pm | N/A 2029-02-12 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 241,898 (Direct) | View |
| 2024-08-20 Exercise | 2024-08-21 6:03 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $16.65 | 241,898 (Direct) | View |
| 2024-08-13 Exercise | 2024-08-15 4:59 pm | N/A 2025-02-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $13.87 | 946,744 (Direct) | View |
| 2024-07-23 Exercise | 2024-07-24 5:48 pm | N/A 2026-02-03 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 221,752 (Direct) | View |
| 2024-07-24 Exercise | 2024-07-24 5:48 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 8,285 | $16.65 | 221,752 (Direct) | View |
| 2024-07-23 Exercise | 2024-07-24 5:48 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 11,715 | $8.11 | 221,752 (Direct) | View |
| 2024-07-22 Exercise | 2024-07-23 4:37 pm | N/A 2025-07-01 | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 5,000 | $0 | 15,480 (Direct) | View |
| 2024-07-22 Exercise | 2024-07-23 4:37 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 5,000 | $22.5 | 15,480 (Direct) | View |
| 2024-06-26 Exercise | 2024-06-28 4:06 pm | N/A 2025-07-01 | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 30,000 | $0 | 60,480 (Direct) | View |
| 2024-06-26 Exercise | 2024-06-28 4:06 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 30,000 | $22.5 | 60,480 (Direct) | View |
| 2024-06-18 Exercise | 2024-06-20 4:17 pm | N/A 2026-02-03 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $0 | 179,891 (Direct) | View |
| 2024-06-18 Exercise | 2024-06-20 4:17 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $8.11 | 179,891 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:17 pm | 2025-06-12 N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 20,137 | $0 | 20,137 (Direct) | View |
| 2024-05-21 Exercise | 2024-05-22 5:24 pm | N/A 2026-02-03 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 221,606 (Direct) | View |
| 2024-05-21 Exercise | 2024-05-22 5:24 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $8.11 | 221,606 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 6:11 pm | N/A 2034-04-25 | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 15,305 | $0 | 128,559 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 6:08 pm | N/A 2034-04-25 | HALOZYME THERAPEUTICS INC. | HALO | Miyashita Akiko Moni Director | 15,305 | $0 | 29,576 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 6:05 pm | N/A 2034-04-25 | HALOZYME THERAPEUTICS INC. | HALO | MATSUI CONNIE Director | 15,305 | $0 | 202,309 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 6:01 pm | N/A 2034-04-25 | HALOZYME THERAPEUTICS INC. | HALO | Krishnan Mahesh Director | 15,305 | $0 | 15,305 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 5:56 pm | N/A 2034-04-25 | HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director | 15,305 | $0 | 62,415 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 5:54 pm | N/A 2034-04-25 | HALOZYME THERAPEUTICS INC. | HALO | Duncan Barbara Gayle Director | 15,305 | $0 | 24,558 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 5:51 pm | N/A 2034-04-25 | HALOZYME THERAPEUTICS INC. | HALO | Connaughton Bernadette Director | 15,305 | $0 | 55,591 (Direct) | View |
| 2024-04-16 Exercise | 2024-04-17 7:22 pm | N/A 2026-02-03 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 261,606 (Direct) | View |
| 2024-04-16 Exercise | 2024-04-17 7:22 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $8.11 | 261,606 (Direct) | View |
| 2024-03-26 Exercise | 2024-03-26 7:38 pm | N/A 2027-02-22 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 11,618 | $0 | 229,891 (Direct) | View |
| 2024-03-26 Exercise | 2024-03-26 7:38 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 292 | $16.78 | 229,891 (Direct) | View |
| 2024-03-26 Exercise | 2024-03-26 7:38 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 8,436 | $12.07 | 229,891 (Direct) | View |
| 2024-03-26 Exercise | 2024-03-26 7:38 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2,890 | $8.11 | 229,891 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-13 5:22 pm | N/A 2027-02-22 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 244,484 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-13 5:22 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 16,449 | $12.07 | 244,484 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-13 5:22 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 3,551 | $8.11 | 244,484 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-28 6:49 pm | N/A 2026-02-03 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 7,471 | $0 | 224,714 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-28 6:49 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 7,471 | $8.11 | 224,714 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:12 pm | 2025-02-23 2034-02-23 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 38,659 | $0 | 38,659 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:08 pm | 2025-02-23 2034-02-23 | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL | 57,109 | $0 | 57,109 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:05 pm | 2025-02-23 2034-02-23 | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 54,473 | $0 | 54,473 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:01 pm | 2025-02-23 2034-02-23 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 182,746 | $0 | 182,746 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-20 6:59 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,376 | $0 | 194,100 (Direct) | View |
| 2024-02-16 Tax Withholding | 2024-02-20 6:59 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 5,257 | $36.1 | 194,100 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-20 6:55 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL | 4,796 | $0 | 26,068 (Direct) | View |
| 2024-02-16 Tax Withholding | 2024-02-20 6:55 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL | 2,577 | $36.1 | 26,068 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-20 6:53 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 10,422 | $0 | 41,653 (Direct) | View |
| 2024-02-16 Tax Withholding | 2024-02-20 6:53 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 5,601 | $36.1 | 41,653 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-20 6:49 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 37,884 | $0 | 769,386 (Direct) | View |
| 2024-02-16 Tax Withholding | 2024-02-20 6:49 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 20,362 | $36.1 | 769,386 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 5:47 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 3,386 | $0 | 167,354 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-16 5:47 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 8,479 | $0 | 167,354 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-16 5:47 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 5,040 | $35.91 | 167,354 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 5:41 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 1,254 | $0 | 11,913 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-16 5:41 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 686 | $35.91 | 11,913 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 5:39 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 13,092 | $0 | 672,314 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-16 5:39 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 32,781 | $0 | 672,314 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-16 5:39 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 24,655 | $35.91 | 672,314 (Direct) | View |
| 2024-02-10 Exercise | 2024-02-13 4:18 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 8,133 | $0 | 157,143 (Direct) | View |
| 2024-02-10 Tax Withholding | 2024-02-13 4:18 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2,901 | $35.49 | 157,143 (Direct) | View |